KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Prepaid Assets: 2018-2024

Historic Prepaid Assets for Esperion Therapeutics (ESPR) over the last 7 years, with Dec 2024 value amounting to $4.2 million.

  • Esperion Therapeutics' Prepaid Assets fell 69.42% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 69.42%. This contributed to the annual value of $4.2 million for FY2024, which is 7.81% down from last year.
  • Esperion Therapeutics' Prepaid Assets amounted to $4.2 million in FY2024, which was down 7.81% from $4.5 million recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Prepaid Assets registered a high of $11.6 million during FY2020, and its lowest value of $4.2 million during FY2024.
  • In the last 3 years, Esperion Therapeutics' Prepaid Assets had a median value of $4.5 million in 2023 and averaged $6.2 million.
  • In the last 5 years, Esperion Therapeutics' Prepaid Assets soared by 90.20% in 2020 and then tumbled by 54.32% in 2023.
  • Esperion Therapeutics' Prepaid Assets (Yearly) stood at $11.6 million in 2020, then dropped by 3.40% to $11.2 million in 2021, then fell by 11.70% to $9.9 million in 2022, then slumped by 54.32% to $4.5 million in 2023, then declined by 7.81% to $4.2 million in 2024.